SB 1185
Removes the expiration date on certain provisions relating to gender transition
Sponsor:
LR Number:
3261S.01I
Committee:
Emerging Issues
Last Action:
1/25/2024 - Second Read and Referred S Emerging Issues Committee
Journal Page:
S233
Title:
Effective Date:
August 28, 2024

Current Bill Summary

SB 1185 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date.

This act is identical to SB 726 (2024) and SB 776 (2024) and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024).

SARAH HASKINS

Amendments

No Amendments Found.